Skip to content
Drug recall · FDA · Published February 21, 2019

Lannett Company Inc. recalls Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc,

Lannett recalls 10mg Oxybutynin Extended-Release Tablets (NDC 62175-271-37) due to failed dissolution specifications. Rx-only medication with specific batch numbers and expiration dates.

🇺🇸 FDA recall #D-0996-2019DrugLannett ›
Take action

Contact the company & request your remedy

Recalling firmLannett Company Inc.1101 C Ave W, N/A · Seymour, IN 47274-3342
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lannett is recalling certain Oxybutynin Chloride extended-release tablets because they may not dissolve properly. This could affect medication effectiveness for people with overactive bladder. Read more at govinfonow.com/recall/39179-lannett-oxybutynin-extended-release-tablets-recall-failed-dissolution-specifications.

Source Summary by GovInfoNow · govinfonow.com/recall/39179-lannett-oxybutynin-extended-release-tablets-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-0996-2019

Cite this page

“Lannett Oxybutynin Extended-Release Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39179-lannett-oxybutynin-extended-release-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0996-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0996-2019%22&limit=1).

Why it’s dangerous

The tablets may not dissolve correctly in the body, which could lead to improper medication delivery. This might reduce the drug's effectiveness for treating overactive bladder.

Who’s affected

People prescribed this medication by a doctor who received the recalled tablets. Those with overactive bladder symptoms are most at risk.

How to tell if you have this one

Check for the product name 'Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet' with NDC 62175-271-37. The recalled batches are Lot 18226783A (exp 07/2021) and Lot 18232540A (exp 08/2021).

  • Brand
    Lannett
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number and batch numbers to confirm if your tablets are recalled.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall is due to potential failure in dissolution specifications, which may affect medication effectiveness. Consult your doctor for advice.

What should I do if I have the recalled tablets?

The recall does not specify a remedy, so contact your doctor for guidance on whether to continue using the medication.

How can I tell if my tablets are recalled?

Check for NDC 62175-271-37 and batch numbers 18226783A (exp 07/2021) or 18232540A (exp 08/2021).

Take action

Contact Lannett

We’ve drafted a message you can send Lannett to request your refund or repair — edit it as you like.

Subject: Recall D-0996-2019 — Lannett Lannett

Hello,

I own a Lannett that is covered by recall D-0996-2019 from Lannett.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0996-2019 (February 21, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0996-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA